Sign in to continue:

Wednesday, July 29th, 2026

FDCTech, Inc. 2025 10-K/A Filing: Business Segments, Acquisitions, and Equity Structure Overview

FDCTech, Inc. (FDCT) 2025 10-K/A: Key Highlights and Shareholder Updates

FDCTech, Inc. (FDCT) 2025 10-K/A: Key Highlights and Shareholder Updates

Overview

FDCTech, Inc., a Delaware-based company in the prepackaged software sector, has filed its amended annual report (10-K/A) for the fiscal year ended December 31, 2025. The company, headquartered in Irvine, California, operates under the EIN 811265459 and trades under the SEC file number 000-56338.

Key Points for Investors

  • Corporate Structure and Name Changes: The company has undergone several rebranding initiatives, including previous names such as FDC Tech, Inc. (2018) and Forex Development Corp. (2017).
  • Restatements & Amendments: The report is an amendment (10-K/A), which signals corrections or clarifications to previously reported financials. Multiple restatement axes are referenced, including original, adjustments, error corrections, and multiple amendment numbers, suggesting significant changes or corrections in historical financial statements across several reporting periods. This level of restatement can often have important implications for investor confidence and stock price.
  • Complex Capital Structure: The company has multiple classes of shares outstanding, including common stock and various series of preferred stock (Series A and Series B Convertible Preferred). Detailed tracking of stock issued, cancelled, and reclassified for both services and capital raises is present, including various transactions involving related parties and directors.
  • Significant Business Acquisitions: The filing includes references to business acquisitions involving entities such as AlchemyPrime Holdings Ltd, AlchemyMarkets Ltd, and AlchemyMarkets DMCC. These acquisitions are reflected in multiple consolidation and equity method entries, with associated restatement and adjustment entries, suggesting that these deals are materially significant to the company’s financials and could impact future performance.
  • Capital Raising and Preferred Share Issuance: There are numerous entries related to the issuance of Series B Preferred Stock for cash and for services, including to key executives and related parties. Several entries indicate the reclassification, cancellation, or adjustment of these shares, which may affect dilution, voting power, and the financial structure of the company.
  • Related Party Transactions: The report includes substantial related party activity, particularly advances, stock issuances, and preferred share transactions involving directors and officers (e.g., Mitchell Eaglstein, Imran Firoz, Gope Kundnani, Felix Hong, William Barnett, and others). These transactions can be material and may raise questions about governance or potential conflicts of interest.
  • Adjustments and Corrections to Financials: There are recurring references to adjustments (Adjustment A-G, OCI re-translation, restated members, etc.) and corrections, particularly in balance sheet items such as accounts receivable, subscription receivable, common and preferred stock values, and related party advances. The frequency and extent of these corrections may be price-sensitive, as they can impact reported earnings, equity, and cash flows.
  • Consolidated Statement Revisions: The company has issued multiple versions of its consolidated financial statements (balance sheet, cash flows, comprehensive income), including originally reported, restated, and amended versions. This indicates ongoing efforts to correct or clarify financial results, which may impact investor perceptions of reliability and transparency.
  • Potential Rounding and Foreign Currency Adjustments: The document references rounding error adjustments and foreign currency translation adjustments, which may affect reported results, particularly given the company’s international acquisitions.
  • CARES Act and PPP Advances: There are references to CARES Act Paycheck Protection Program advances, though specific amounts are not detailed in the excerpts, indicating that the company may have participated in government assistance programs and these may impact its liabilities or cash position.
  • Commitments, Contingencies, and Guarantees: The report references commitments, contingencies, and related party guarantees, though specific details are not provided in the excerpts. These could be material and may affect future cash flows or financial stability.

Potential Price-Sensitive Issues for Shareholders

  • Restatements and Corrections: The volume and complexity of restatements, amendments, and corrections may signal prior errors or misstatements in financials. This could be a red flag for investors, potentially impacting market confidence and share value. Investors should closely monitor management’s disclosures regarding the nature, cause, and impact of these restatements.
  • Share Issuance and Dilution: Substantial issuance of Series B Convertible Preferred Stock for both cash and services, including to insiders and related parties, may lead to dilution of existing equity holders. The company’s capital raising activities appear to be ongoing and complex, which may affect the share price as new shares are issued or converted.
  • Business Acquisitions: The acquisitions of entities such as AlchemyPrime Holdings Ltd and AlchemyMarkets could be transformative. If successful, these could enhance revenue streams and international expansion, but also bring integration risks and potential for further financial restatements if accounted for improperly.
  • Related Party Activity: Extensive related party transactions, including stock issuances and advances, can be a governance concern and may affect financial statement reliability if not properly disclosed or managed.
  • Government Assistance and Contingent Liabilities: Participation in CARES Act programs and the presence of undisclosed commitments and contingencies could materially affect the company’s future liability profile and cash flows.

Conclusion

The FDCTech, Inc. 10-K/A for 2025 reveals a company in the midst of significant corporate and financial restructuring, with numerous restatements, complex capital transactions, and major acquisitions. While these activities may position the company for growth, they also introduce considerable uncertainty and potential risk for current and prospective shareholders. The frequency of financial corrections and related party transactions in particular could be price-sensitive and should be monitored closely.

Disclaimer

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should review the full SEC filings and consult with their financial advisor before making any investment decisions. The information contained herein is based on extracts from the company’s 10-K/A filing and is subject to change or correction by the company and regulatory authorities.


View FDCTECH, INC. Historical chart here



Allurion Technologies, Inc. Announces New SEC Filing and Executed Agreements – Details Inside

Allurion Technologies Announces Exchange Agreement with RTW ...

Aqua Metals Executive Compensation and Governance: 2024-2025 Summary

Aqua Metals, Inc. 10-K/A Detailed Investor Report Aqua...